Skip to content

Author

J. van Loosdregt

We have 3 of 72 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Complement activation linked to type II interferon signaling in Still disease.

OBJECTIVE Still disease (SD) is an autoinflammatory syndrome characterized by innate immune dysregulation. While complement can drive inflammation, its involvement in SD remains to be defined. Thus, we aimed to assess complement activation in SD. METHODS Complement was assessed using transcriptomic, proteomic, and in...

F. Huijsmans, Tabea Thalheim, A. Bodelón et al. · 0 citations

can modulate TAL1 transcriptional activity through interaction with LMO2

Initial evidence for a novel role of FOXP3 as a tumor suppressor in T-ALL through modulation of TAL1 transcriptional activity is provided through modulation of TAL1 transcriptional activity.

V. Fleskens, M. Mokry, A. M. van der Leun et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.